OBJECTIVE: To determine whether serum N-terminal pro-B-type natriuretic peptide (N-BNP), a biomarker of myocardial wall stress, is specific to acute heart failure (HF) in patients hospitalized with stroke. DESIGN: Case-control study. SETTING: Tertiary hospital, Neurosciences Critical Care Unit and Stroke Unit. PATIENTS: Consecutive patients with acute ischemic or hemorrhagic stroke who were evaluated for HF. INTERVENTION: None. MEASUREMENTS AND RESULTS: Cases and controls were classified, respectively, as patients with or without HF, defined according to modified Framingham criteria. Seventy-two patients were evaluated, 39 with ischemic stroke, 22 with aneurysmal subarachnoid hemorrhage (SAH), and 11 with intracerebral hemorrhage (ICH). Thirty-four patients (47%) met criteria for HF, and 47 patients (65%) had systolic or diastolic left ventricular (LV) dysfunction on echocardiogram. Serum N-BNP was measured a median of 48 h following the onset of stroke and was increased (> 900 pg/ml) in 56 patients (78%), with higher levels in non-survivors (11898 +/- 12741 vs 4073 +/-5691; p = 0.001). In a multiple regression model, N-BNP elevation was not independently associated with HF (OR 5.4, 95% CI 0.8-36.0, p = 0.084). At a cut-off of 900 pg/ml, the sensitivity of N-BNP for HF was 94%, specificity 37%, positive predictive value (PPV) 57%, and negative predictive value (NPV) 88%. For systolic or diastolic LV dysfunction, the sensitivity of N-BNP was 89%, specificity 44%, PPV 75%, and NPV 69%. CONCLUSIONS: These results demonstrate that N-BNP elevation is not specific to HF or LV dysfunction in patients with acute ischemic stroke, SAH, and ICH.
OBJECTIVE: To determine whether serum N-terminal pro-B-type natriuretic peptide (N-BNP), a biomarker of myocardial wall stress, is specific to acute heart failure (HF) in patients hospitalized with stroke. DESIGN: Case-control study. SETTING: Tertiary hospital, Neurosciences Critical Care Unit and Stroke Unit. PATIENTS: Consecutive patients with acute ischemic or hemorrhagic stroke who were evaluated for HF. INTERVENTION: None. MEASUREMENTS AND RESULTS: Cases and controls were classified, respectively, as patients with or without HF, defined according to modified Framingham criteria. Seventy-two patients were evaluated, 39 with ischemic stroke, 22 with aneurysmal subarachnoid hemorrhage (SAH), and 11 with intracerebral hemorrhage (ICH). Thirty-four patients (47%) met criteria for HF, and 47 patients (65%) had systolic or diastolic left ventricular (LV) dysfunction on echocardiogram. Serum N-BNP was measured a median of 48 h following the onset of stroke and was increased (> 900 pg/ml) in 56 patients (78%), with higher levels in non-survivors (11898 +/- 12741 vs 4073 +/-5691; p = 0.001). In a multiple regression model, N-BNP elevation was not independently associated with HF (OR 5.4, 95% CI 0.8-36.0, p = 0.084). At a cut-off of 900 pg/ml, the sensitivity of N-BNP for HF was 94%, specificity 37%, positive predictive value (PPV) 57%, and negative predictive value (NPV) 88%. For systolic or diastolic LV dysfunction, the sensitivity of N-BNP was 89%, specificity 44%, PPV 75%, and NPV 69%. CONCLUSIONS: These results demonstrate that N-BNP elevation is not specific to HF or LV dysfunction in patients with acute ischemic stroke, SAH, and ICH.
Authors: Philippe Gabriel Steg; Laurence Joubin; James McCord; William T Abraham; Judd E Hollander; Torbjorn Omland; France Mentré; Peter A McCullough; Alan S Maisel Journal: Chest Date: 2005-07 Impact factor: 9.410
Authors: Eric A Espiner; Robert Leikis; Richard D Ferch; Martin R MacFarlane; Janusz A Bonkowski; Christopher M Frampton; A Mark Richards Journal: Clin Endocrinol (Oxf) Date: 2002-05 Impact factor: 3.478
Authors: S E Kasner; J A Chalela; J M Luciano; B L Cucchiara; E C Raps; M L McGarvey; M B Conroy; A R Localio Journal: Stroke Date: 1999-08 Impact factor: 7.914
Authors: Duncan J Campbell; Mark Woodward; John P Chalmers; Samuel A Colman; Alicia J Jenkins; Bruce E Kemp; Bruce C Neal; Anushka Patel; Stephen W MacMahon Journal: Hypertension Date: 2004-11-29 Impact factor: 10.190
Authors: H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao Journal: Circulation Date: 1994-07 Impact factor: 29.690
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2008-01-31 Impact factor: 17.440
Authors: Francesco Ruggieri; Marco Gemma; Maria Rosa Calvi; Elisa Nicelli; Andrea Agarossi; Luigi Beretta Journal: Neurocrit Care Date: 2012-12 Impact factor: 3.210
Authors: Michael L James; Robert Blessing; Barbara G Phillips-Bute; Ellen Bennett; Daniel T Laskowitz Journal: Biomarkers Date: 2009-09 Impact factor: 2.658
Authors: Seo Hyun Kim; Ji-Yong Lee; Sang Hyun Park; Hyun-Chan Jang; Eun Ju Lim; Sei-Jin Chang; Sung-Soo Lee Journal: Int J Med Sci Date: 2012-12-27 Impact factor: 3.738